Hikma Pharmaceutical reported 116.14B in Loan Capital for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
AstraZeneca AZN:LN 2229663.86M 36335.94M
Bayer BAYN:GR € 38061M 1413M
Fresenius FRE:GR € 24634M 1357M
Galapagos GLPG:NA 16.88M 1.41M
Genmab GEN:DC 554M 198M
GlaxoSmithKline GSK:LN 1878400M 1044200M
Hikma Pharmaceutical HIK:LN 116.14B 62.55B
Lonza Group LONN:SW 1.95B 287M
Merck MRK:GR € 9385M 1099M
Orion ORNBV:FH 203.3M 116.7M
Recordati REC:IM 1.45B 46.64M